Review drug intelligence surfaces
Use this page to evaluate pricing pressure, category-level ASP shock, and mapping coverage
quality before deeper pharmacy or infusion workflow decisions.
Curated drug codes: 42
ASP codes tracked: 875
Fully covered mappings: 1
Source snapshot: cms.drug-curated.2025@2025-11 · Schema: intelligence.drugs.margin-pressure.v1
O7 · Drug Margin Pressure Board
Compare acquisition context and charge ranges for curated HCPCS drug codes.
Observed support
Coverage 100.00%
Join success 100.00%
Curated HCPCS drug set has complete acquisition and charge context for the surfaced rows.
Support: 50 of 50 entities met support thresholds.
Snapshot cms.drug-curated.2025@2025-11 · Schema intelligence.drugs.margin-pressure.v1 · Generated 4/6/2026
Spread between curated acquisition context and typical charge ranges for selected drug codes.
- Curated code must have acquisition cost and charge-range fields
- Category classification required for inclusion
- Curated reference context, not complete payer reimbursement logic.
- Not a fraud or adjudication determination model.
Distribution + intensity
Bubble size represents weighted context volume.
Bubble chart plotting Acquisition cost ($) against High markup (%) for 40 points. Bubble size represents weighted context volume.
- 40 bubble points shown.
- J1745 has the highest acquisition cost ($) at 113.06.
- J0665 has the highest high markup (%) at 272,008.84.
Acquisition cost ($) and High markup (%) bubble chart table| Label | Acquisition cost ($) | High markup (%) | Bubble size |
|---|
| J0665 | 0.074 | 272,008.84 | 5 |
| J1836 | 0.02 | 249,900 | 5 |
| J0461 | 0.06 | 166,566.67 | 5 |
| J7620 | 0.085 | 117,547.06 | 5 |
| J0131 | 0.045 | 111,011.11 | 5 |
| J0134 | 0.045 | 111,011.11 | 5 |
| J3480 | 0.1 | 49,900 | 5 |
| J3475 | 0.25 | 39,900 | 5 |
| J7613 | 0.2 | 37,400 | 5 |
| J2550 | 0.1 | 34,900 | 5 |
| J7030 | 2.45 | 28,471.43 | 5 |
| J7040 | 2.45 | 28,471.43 | 5 |
| J1920 | 0.4 | 24,900 | 5 |
| J3010 | 0.08 | 18,650 | 5 |
| J0153 | 0.42 | 17,757.14 | 5 |
| J0330 | 0.15 | 16,566.67 | 5 |
| Q0162 | 0.22 | 14,518.18 | 5 |
| J1100 | 0.2 | 12,400 | 5 |
| J1171 | 0.05 | 11,900 | 5 |
| J1644 | 0.22 | 11,263.64 | 5 |
| J2704 | 0.046 | 10,769.57 | 5 |
| J2250 | 0.12 | 9,900 | 5 |
| J7070 | 3.36 | 9,513.1 | 5 |
| J2405 | 0.35 | 8,471.43 | 5 |
| J1745 | 113.06 | 6,091.4 | 17.5 |
| J1885 | 0.75 | 5,233.33 | 5 |
| J1956 | 0.75 | 5,233.33 | 5 |
| J1200 | 1 | 4,900 | 5 |
| A4216 | 0.5 | 4,900 | 5 |
| J1650 | 2.3 | 4,247.83 | 5 |
| J7120 | 2.45 | 3,981.63 | 5 |
| J2270 | 1.5 | 3,233.33 | 5 |
| J0690 | 0.75 | 3,233.33 | 5 |
| J0696 | 0.45 | 3,233.33 | 5 |
| J0456 | 1.5 | 3,233.33 | 5 |
| J1741 | 2.5 | 3,100 | 5 |
| J1170 | 2 | 2,900 | 5 |
| J2765 | 1 | 2,900 | 5 |
| J2543 | 3.75 | 2,566.67 | 5 |
| J3370 | 2.25 | 2,122.22 | 5 |
O8 · ASP Shock Tracker
Spot payment-limit outliers by category to prioritize quarterly ASP validation work.
Observed support
Coverage 100.00%
Join success 100.00%
ASP payment-limit coverage is complete for the tracked quarterly code set.
Support: 876 of 876 entities met support thresholds.
Snapshot cms.asp.2026q1@2026-03-31T18:58:47.764Z · Schema intelligence.drugs.asp-shock-tracker.v1 · Generated 4/6/2026
HCPCS drug payment limits compared with their category median to highlight outlier pressure.
- ASP payment limit must be present for included code
- Category median is computed only from available category members
- Single-quarter ASP snapshot; this view does not infer trend direction without historical quarters.
- Category mapping uses curated references and is not a contract reimbursement predictor.
Compare two measures
Horizontal bar chart comparing Payment limit and Category median across 12 categories.
- 12 categories compared across Payment limit and Category median.
- Q2057 has the highest payment limit at 770,620.
- Q2057 has the highest category median at 14.904.
Payment limit and Category median comparison table| Category | Payment limit | Category median |
|---|
| Q2057 | 770,620 | 14.904 |
| Q2056 | 587,649.574 | 14.904 |
| Q2042 | 566,531.304 | 14.904 |
| Q2054 | 562,201.242 | 14.904 |
| Q2055 | 558,081.726 | 14.904 |
| Q2041 | 532,192.241 | 14.904 |
| Q2053 | 489,450.202 | 14.904 |
| J3402 | 201,669.021 | 14.904 |
| J9029 | 64,274.791 | 14.904 |
| Q2043 | 54,404.108 | 14.904 |
| J9226 | 43,185.339 | 14.904 |
| J9266 | 28,424.059 | 14.904 |
O9 · NDC-HCPCS Coverage Gaps
Validate whether curated HCPCS mappings are fully covered by crosswalk and NADAC references.
Derived support
Coverage 70.94%
Join success 70.94%
Crosswalk/NADAC linkage is high but not complete; unmapped rows are retained as explicit coverage gaps.
Support: 691 of 974 entities met support thresholds.
Snapshot cms.ndc-hcpcs-crosswalk.2025q4@2025-11-27 · Schema intelligence.drugs.ndc-hcpcs-coverage-gaps.v1 · Generated 4/6/2026
Coverage completeness between curated HCPCS drug mappings, crosswalk NDC links, and NADAC references.
- Crosswalk and NADAC joins are required for full-coverage classification
- Unmapped codes are surfaced instead of dropped
- Coverage is mapping completeness, not reimbursement adequacy.
- Some gaps reflect source timing differences across public files.
Composition by category
Stacked horizontal bar chart showing NADAC-mapped NDCs and Missing NADAC links by category.
- 12 categories shown with stacked values for NADAC-mapped NDCs and Missing NADAC links.
- Q9967 has the highest combined total at 92.
NADAC-mapped NDCs and Missing NADAC links stacked share table| Category | NADAC-mapped NDCs | Missing NADAC links | Total |
|---|
| Q9967 | 0 | 92 | 92 |
| J3475 | 0 | 56 | 56 |
| J3480 | 0 | 43 | 43 |
| J0153 | 0 | 30 | 30 |
| J0461 | 0 | 26 | 26 |
| J7070 | 0 | 23 | 23 |
| A9585 | 0 | 21 | 21 |
| J0282 | 0 | 17 | 17 |
| J1956 | 0 | 16 | 16 |
| J0131 | 0 | 10 | 10 |
| J1836 | 0 | 7 | 7 |
| J1741 | 0 | 2 | 2 |
Have a medical bill?
Upload it and check line items against Medicare benchmarks, NCCI bundling rules, and pricing data.
Open Bill Analyzer
Boundary
Spread between curated acquisition context and typical charge ranges for selected drug codes.
Supports pricing review prioritization by highlighting margin pressure patterns worth validating locally.
- Curated reference context, not complete payer reimbursement logic.
- Not a fraud or adjudication determination model.